Kathleen Tregoning Spero Therapeutics, Inc. (SPRO) insider trading activity

Kathleen Tregoning is of Spero Therapeutics, Inc.. Currently has a direct ownership of 55,000 shares of SPRO, which is worth approximately $52,800. The most recent transaction as insider was on May 29, 2024, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55K

0% 3M change

57.14% 12M change

Total Value Held $52,800

Kathleen Tregoning Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	BUY Grant, award, or other acquisition	-	20,000 Added 26.67%	55,000 Common Stock
Oct 05 2023	BUY Grant, award, or other acquisition	-	20,000 Added 36.36%	35,000 Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Common Stock

Also insider at

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare